Why the study?
Do evidence-based integrated therapeutic strategies improve long-term heart transplant-free survival in patients with idiopathic dilated cardiomyopathy?
Do evidence-based integrated therapeutic strategies improve long-term heart transplant-free survival in patients with idiopathic dilated cardiomyopathy?
The progressive implementation of evidence-based integrated therapeutic approaches, including tailored medical therapy and ICDs, has significantly improved the long-term prognosis of idiopathic dilated cardiomyopathy over the last three decades.
No takes yet. Share an insight, caveat, or question.
Improved survival in idiopathic dilated cardiomyopathy supports ongoing evidence-based care; leaves open causal effects of integrated strategies.
Merlo et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: